nafronyl has been researched along with Brain Injuries in 1 studies
Nafronyl: A drug used in the management of peripheral and cerebral vascular disorders. It is claimed to enhance cellular oxidative capacity and to be a spasmolytic. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1310) It may also be an antagonist at 5HT-2 serotonin receptors.
Brain Injuries: Acute and chronic (see also BRAIN INJURIES, CHRONIC) injuries to the brain, including the cerebral hemispheres, CEREBELLUM, and BRAIN STEM. Clinical manifestations depend on the nature of injury. Diffuse trauma to the brain is frequently associated with DIFFUSE AXONAL INJURY or COMA, POST-TRAUMATIC. Localized injuries may be associated with NEUROBEHAVIORAL MANIFESTATIONS; HEMIPARESIS, or other focal neurologic deficits.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Effects of naftidrofuryl oxalate (LS-121) on experimental amnesia models, which were induced by cycloheximide (CXM), scopolamine (SCOP) and basal-forebrain (BF) lesion, were investigated using the step-through passive avoidance response in rats." | 3.67 | [Effect of naftidrofuryl oxalate (LS-121) on experimental amnesia model in rats]. ( Kameyama, T; Katoh, A; Nabeshima, T; Ogawa, S, 1988) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Kameyama, T | 1 |
| Nabeshima, T | 1 |
| Katoh, A | 1 |
| Ogawa, S | 1 |
1 other study available for nafronyl and Brain Injuries
| Article | Year |
|---|---|
[Effect of naftidrofuryl oxalate (LS-121) on experimental amnesia model in rats].
Topics: Amnesia; Animals; Avoidance Learning; Brain Injuries; Cycloheximide; Disease Models, Animal; Furans; | 1988 |